Compounded Semaglutide Shelf Life After Opening

Last reviewed: May 23, 2026

Last updated: May 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Compounded semaglutide typically remains stable and safe for 28 days after initial use when properly refrigerated at 2–8°C (36–46°F). This timeframe applies to single-use or multi-dose vials from licensed 503A compounding pharmacies, which compound medications under strict USP standards to match pharmaceutical-grade quality.

Knowing your medication's shelf life after opening is critical for maintaining consistent treatment and avoiding gaps in your therapy. PlexusDx prioritizes patient education on medication stewardship so you can take an active role in your care while working with your provider to optimize your dosing schedule.

Understanding Compounded Semaglutide Stability Post-Opening

Once opened, compounded semaglutide remains chemically stable for up to 28 days under refrigeration. This stability window is based on pharmaceutical testing protocols that verify potency, purity, and sterility throughout the storage period. Different compounding pharmacies may provide slightly different expiration timeframes based on their formulation.

Temperature consistency matters significantly. Leaving your semaglutide at room temperature or exposing it to heat degrades the peptide structure, reducing efficacy and potentially creating safety concerns. A dedicated medication compartment in your refrigerator—away from the back where it's coldest—helps maintain optimal conditions.

Compounded vs. Branded Semaglutide: Storage and Stability Comparison

Compounded semaglutide from licensed 503A pharmacies follows USP standards for stability and potency verification. Understanding how your specific formulation compares to other options helps you make informed decisions with your provider about which product best fits your lifestyle and treatment goals.

The table below outlines key differences in post-opening shelf life, storage requirements, and clinical considerations across common semaglutide delivery options.

Product Type	Shelf Life After Opening	Storage Temperature	Provider Coordination
Compounded Semaglutide (503A Pharmacy)	Up to 28 days	2–8°C refrigerated	Prescription required; custom dosing possible
Branded Semaglutide (e.g., Ozempic, Wegovy)	Typically 28–30 days	2–8°C refrigerated	Pre-set dosing; requires branded prescription
Microdose Compounded Protocols	Up to 28 days	2–8°C refrigerated	Lower starting doses; titration flexibility
Oral Semaglutide Tablets	Per manufacturer/pharmacy label	Room temperature (varies)	Separate mechanism; different storage rules apply

Best Practices for Tracking and Using Your Open Vial

Label your vial with the opening date using a waterproof marker as soon as you first use it. Many patients benefit from setting phone reminders at day 25 to alert them that their current vial expires in 3 days, ensuring they have a refill ready before running out. This prevents treatment gaps.

Never reuse a vial past its 28-day window, even if it appears clear and unchanged. Visual appearance doesn't indicate chemical integrity or sterility. Discard expired compounded medication according to pharmacy guidelines or local pharmaceutical disposal programs, and contact your provider immediately to obtain a fresh supply.

Medical Considerations and When to Involve Your Provider

Your treatment plan should align with your vial's open-date timeline. If you inject multiple times weekly, your 28-day supply depletes faster than if you dose once weekly. A qualified provider can adjust your prescription frequency and vial size to match your injection schedule and minimize waste or gaps.

Certain genetic predispositions in peptide pathways—detectable through the Precision Peptide Genetic Test—may influence how quickly you reach therapeutic response, which can inform dosing timing and vial-use planning. Always discuss medication stability and refill logistics during your initial and follow-up consultations.

How PlexusDx Supports a More Personalized Approach

Understanding your compounded semaglutide's post-opening stability window may help provide context for treatment planning and medication stewardship. PlexusDx partners with licensed 503A compounding pharmacies that follow USP standards, meaning your compounded semaglutide undergoes rigorous stability and potency verification. This precision approach supports consistent dosing and clinical outcomes.

The Precision Peptide Genetic Test reveals genetic predispositions in peptide pathways (including GIPR rs1800437, GLP1R rs6923761, and MC4R rs17782313) that may influence how your body metabolizes GLP-1 medications. While genetics does not predict exact medication response, understanding your peptide genetic profile can support a more informed conversation with your provider about treatment timing, dosing adjustments, and medication continuity planning.

When you combine knowledge of your vial's 28-day shelf life with personalized peptide genetic context, you and your provider can make more strategic decisions about prescription intervals, refill scheduling, and whether adjustments to dose frequency might better suit your genetic predispositions and lifestyle. This integrated approach reinforces medication adherence and optimizes therapeutic potential.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How does the post's comparison table line up compounded semaglutide's post-opening window against branded pens?

The table gives compounded semaglutide from a 503A pharmacy up to 28 days after opening and branded semaglutide such as Ozempic or Wegovy typically 28 to 30 days, both under refrigeration at 2 to 8 degrees Celsius. It lists microdose compounded protocols at up to 28 days and notes that oral semaglutide tablets follow the manufacturer or pharmacy label instead.

Why does the article say a vial that still looks clear can be past its usable window?

The post states that visual appearance does not indicate chemical integrity or sterility, so a vial can look completely unchanged and still be outside its 28-day window. It says expired compounded medication should be discarded through pharmacy guidelines or local pharmaceutical disposal programs, and the prescriber contacted for a fresh supply.

Does the post say every compounding pharmacy uses the same 28-day figure?

No. The article says different compounding pharmacies may provide slightly different expiration timeframes based on their formulation, so 28 days is a common benchmark rather than a universal rule. The dispensing pharmacy's own label remains the authority for any particular vial, and the post directs questions there and to the prescribing provider.

Why does the post say someone injecting more than once a week runs through a vial faster?

The article explains that a 28-day supply depletes faster when injections happen multiple times weekly than when they happen once weekly, so the open-date timeline and the treatment plan have to line up. It says a qualified provider can adjust prescription frequency and vial size to match the schedule and minimize both waste and gaps.

What does the article say heat exposure does to compounded semaglutide?

The post says leaving compounded semaglutide at room temperature or exposing it to heat degrades the peptide structure, reducing efficacy and potentially creating safety concerns. It treats temperature consistency as the main variable behind the stated stability window. Specific handling requirements come from the dispensing pharmacy's label, not from the article.

Related Reading

• Compounded Semaglutide 2
• Compounded Semaglutide
• Medvi Semaglutide
• Bioverse Semaglutide

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.